Pulmonary and cutaneous sarcoidosis associated with interferon therapy for melanoma

Cutis

Volumn 80, Issue 5, 2007, Pages 441-445

  Pelletier, Fabien ^a,b,c   Manzoni, Philippe ^a,b   Jacoulet, Pascale ^a,b   Humbert, Philippe ^a,b   Aubin, François ^a,b  

^a Department of Dermatology ^*

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c HÔPITAL SAINT JACQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; HUMAN; MALE; MELANOMA; MIDDLE AGED; SARCOIDOSIS; SKIN DISEASE;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; HUMANS; INTERFERON-ALPHA; MALE; MELANOMA; MIDDLE AGED; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SKIN DISEASES;

EID: 37049016650     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Kirkwood JM, Ibrahim JG, Sosman JA, et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol. 2001;19:2370-2380.
2. Kirkwood JM, Ibrahim JG, Sondak VK, et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol. 2000;18:2444-2458.
3. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol. 1996;14: 7-17.
4. Molife R, Hancock BW. Adjuvant therapy of malignant melanoma. Clin Rev Oncol Hematol. 2002;44:81-102.
5. Conlon KC, Urba WJ, Smith JW, et al. Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer. 1990;65: 2237-2242.
6. Marzouk K, Saleh S, Kannass M, et al. Interferon-induced granulomatosis lung disease. Curr Opin Pulm Med. 2004;10:435-440.
7. Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol. 1996;25:283-291.
8. Salvio A, Mormile M, Giannattasio F, et al. Pulmonary sarcoidosis during interferon therapy: a rare or underestimated event? Ann Ital Med Int. 2004;19:58-62.
9. Miwa H, Furuya T, Tanaka S, et al. Neurosarcoidosis associated with interferon therapy. Eur Neurol. 2001;45: 288-289.
10. Abdi EA, Nguyen GK, Ludwig RN, et al. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer. 1987;59:896-900.
11. Bobbio-Pallavicini E, Valsecchi C, Tacconi F, et al. Sarcoidosis following beta-interferon therapy for multiple myeloma. Sarcoidosis. 1995;12:140-142.
12. Husa P, Klusakova J, Jancikova J, et al. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis B. Eur J Intern Med. 2002;13:129-131.
13. Cogrel O, Doutre MS, Marliere V, et al. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. Br J Dermatol. 2002;146:320-324.
14. Perez-Alvarez R, Perez-Lopez R, Lombrana JL, et al. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. J Viral Hepat. 2002;9:75-79.
15. Gitlin N. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. Eur J Gostroenterol Hepatol. 2002;14: 883-885.
16. Hoffmann RM, Jung MC, Motz R, et al. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. J Hepatol. 1998;28:1058-1063.
17. Cacoub P, Sbai A, Frances C, et al. Systemic sarcoidosis during interferon-alfa therapy for chronic hepatitis C virus infection [in French]. Gastroenterol Clin Biol. 2000;24: 364-366.
18. Rubinowitz AN, Naidich DP, Alinsonorin C. Interferon-induced sarcoidosis. J Comput Assist Tomogr. 2003;27: 279-283.
19. Wendling J, Descamps V, Grossin M, et al. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C. Arch Dermatol. 2002;138:546-547.
20. Papaioannides D, Fotinou M, Korantzopoulos P, et al. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. Med Sci Monit. 2004;10: CS5-CS7.
21. Nawras A, Alsolaiman MM, Mehboob S, et al. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci. 2002;47:1627-1631.
22. Pietropaoli A, Modrak J, Utell M. Interferon-alpha therapy associated with the development of sarcoidosis. Chest. 1999;116:569-572.
23. Mehta CL, Tyler RJ, Cripps DJ. Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon beta-1b injections. J Am Acad Dermatol. 1998;39:1024-1028.
24. Frankova H, Gaja A, Hejlova N. Pulmonary sarcoidosis in a patient with essential thrombocythemia treated with interferon alpha: a short case report. Med Sci Monit. 2000;6:380-382.
25. Parronchi P, Mohapatra S, Sampognaro S, et al. Effects of interferon-alpha on cytokine profile, T cell receptor repertoire and peptide reactivity of human allergen-specific T cells. Eur J Immunol. 1996;26:697-703.
26. Leclerc S, Myers RP, Moussalli J, et al. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med. 2003;14:237-243.
27. Ravenel JG, McAdams HP, Plankeel JF, et al. Sarcoidosis induced by interferon therapy. AJR Am J Roentgenol. 2001;177:199-201.
28. Rogers CJ, Romagosa R, Vincek V. Cutaneous sarcoidosis associated with pegylated interferon alpha and ribavirin therapy in a patient with chronic hepatitis C. J Am Acad Dermatol. 2004;50: 649-650.
29. Toulemonde A, Quereux G, Dréno B. Sarcoidosis granuloma on a tattoo induced by interferon alpha [in French]. Ann Dermatol Venereal. 2004;131(1 pt 1): 49-51.
30. Massaguer S, Sanchez M, Castel T. Mediastinal sarcoidosis induced by high-dose alpha-2-interferon therapy in a patient with malignant melanoma. Eur Radiol. 2004;14:1716-1717. Epub Jan 22, 2004.
31. Robert C, Schoenlaub P, Avril MF, et al. Malignant melanoma and granulomatosis. Br J Dermatol. 1997;137: 787-792.
32. O'Connell MJ, Schimpff SC, Kirschner RH, et al. Epitheliod granulomes in Hodgkin disease, a favorable prognostic sign? JAMA. 1975;233: 886-889.